News Articles for Alan Tribe

Perth biotech PYC Therapeutics will go to market seeking $653 million to advance four of its treatments through early trial stages and towards their first transaction.

Perth-based biotech company PYC Therapeutics is on the hunt for a full-time managing director, following the resignation of Dr Rohan Hockings.

The multinational retailer previously leased the Innaloo property on a contract set to expire in 2026.

Perth-based PYC Therapeutics is battling to complete its $146 million capital raising after a large shortfall from retail investors and a “liquidity” issue by one of its underwriters.

Nedlands-based biotech company PYC Therapeutics is rattling the tin for up to $146 million to fund the progression of four novel drug candidates.

The 4.29ha landholding was purchased by the Public Transport Authority, in WA's largest industrial sale of the year.

A 4.29-hectare lot owned by Perth businessman Alan Tribe, which was understood to be previously earmarked for an IKEA store, will soon hit the market.

Mining entrepreneur Mark Creasy has bought a Nedlands commercial property from Alan Tribe's Delarge Investments.

Nedlands-based biotechnology company PYC Therapeutics has raised $30 million to progress its series of drug trials.

The pandemic did little to deter some of Perth's most prominent business leaders from opening their wallets for luxury homes.

The updated WA ‘rich list' shows the state's iron ore magnates are moving far ahead of people who made their money in other industries.

The rising fortunes of biotech company PYC Therapeutics have bolstered the wealth of its major shareholders, most notably chairman Alan Tribe.

Biotech company PYC Therapeutics has sought funding for its lead drug development program that aims to treat childhood blindness.

Biotech company Phylogica announced it had increased its shareholding in Vision Pharma to 90 per cent, following a $15 million investment using funds it had raised through a recent rights issue.

Biotech company Phylogica has announced plans to raise $26.8 million through a rights issue, fully underwritten by chairman and major shareholder Alan Tribe, with the proceeds used primarily to fund preclinicial studies for its leading drug molecule.

Phylogica has announced a commercial collaboration with Lions Eye Institute trading under the name Vision Pharma, bringing the biotechnology company a step closer to commercialising its drug delivery technology.

Shares in biomedical technology business Phylogica were up 13 per cent today after the company announced it had completed a $9.1 million recapitalisation.

Phylogica has a new chief executive who is determined to bring the Perth biotech's commercialisation strategy to fruition.

Former IKEA franchise owner Alan Tribe has taken charge at local biotech firm Phylogica, lifting his stake to 20 per cent and becoming chairman on the same day chief executive Stephanie Unwin was replaced by Rohan Hockings.

Sydney-based GDI Property Group has set its sights on Perth's IKEA complex in a conditional deal worth $143.5 million.